Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Pharmafile.com’s weekly COVID-19 news round-up

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
News

Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …
Appointment

Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020 Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …
News

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020 Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
News

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
News

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …
Appointment

Sage Therapeutics to halve its total workforce in radical cost-cutting move

April 8, 2020 Research and Development, Sales and Marketing Sage Therapeutics, pharma, staff cuts

Sage Therapeutics has revealed a radical restructuring effort to cut costs and “enable the company to advance its corporate strategy …
News

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020 Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …
News

FDA approval for BMS and Acceleron’s Reblozyl to reduce red blood cell transfusion dependence

April 6, 2020 Manufacturing and Production, Sales and Marketing BMS, FDA, Reblozyl, pharma

The FDA has given the regulatory thumbs-up in the US of Reblozyl (luspatercept-aamt), the “first and only erythroid maturation agent” …
News

British Health Secretary says more patients with COVID-19 are needed for clinical trials

April 6, 2020 Sales and Marketing COVID-19, UK, clinical trials, coronavirus

Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials …
News

European approval for Novo’s Rybelsus to control blood sugar in type 2 diabetes

April 6, 2020 Sales and Marketing Novo Nordisk, Rybelsus, diabetes, pharma

The European Commission has greenlighted Novo Nordisk’s Rybelsus (oral semaglutide) as an adjunct to diet and exercise to improve glycaemic …
News

Trump again tells people to take Hydroxychloroquine to treat COVID-19, despite a lack of evidence

April 6, 2020 Sales and Marketing COVID-19, chloroquine, coronavirus, hydrochloroquine, hydroxychloroquine

President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its …
News

Pfizer scores EU approval for MabThera biosimilar Ruxience

April 6, 2020 Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar

The European Commission has moved to authorise Ruxience, Pfizer’s biosimilar version of MabThera (rituximab).  The decision marks the seventh biosimilar …
News

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
Appointment

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
Appointment
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026